Farther Finance Advisors’s Immunocore IMCR Stock Holding History

Farther Finance Advisors’s Portfolio IMCR Stock Details IMCR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$727	Sell	24 -37	-61%	-$1.26K	﹤0.01%	5668
2026 Q2	$1.91K	Sell	61 -46	-43%	-$1.36K	﹤0.01%	5184
2026 Q1	$3.24K	Sell	107 -124	-54%	-$4.01K	﹤0.01%	4701
2025 Q4	$8.02K	Buy	231 +154	+200%	+$5.44K	﹤0.01%	4055
2025 Q3	$2.8K	Buy	+77	New	+$2.62K	﹤0.01%	4005
2024 Q3	–	Sell	-99	Closed	-$3.61K	–	4064
2024 Q2	$3.61K	Buy	+99	New	+$5.05K	﹤0.01%	2540

Other funds holding IMCR

JWS

Juncture Wealth Strategies Scottsdale, Arizona $390M AUM 19.15% 1-Year Est. Return

GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return

CoreCap Advisors Southfield, Michigan $3.48B AUM 21.43% 1-Year Est. Return

Farther Finance Advisors's IMCR Position: Q3 2026 in Review

Farther Finance Advisors reduced its Immunocore (IMCR) stake by 61% in Q3 2026, selling an estimated $1.26K and leaving 24 shares worth $727. The position accounts for ﹤0.01% of the portfolio, ranked #5668.

Farther Finance Advisors first reported a position in IMCR in Q2 2024 and has held it in 6 quarters since. The position peaked at $8.02K in Q4 2025. 4 funds tracked by Wall St. Rank hold IMCR as of Q3 2026.

Farther Finance Advisors held 24 shares of Immunocore worth $727 as of Q3 2026.
Farther Finance Advisors sold 37 Immunocore shares in Q3 2026, an estimated $1.26K.
Immunocore made up ﹤0.01% of Farther Finance Advisors's portfolio in Q3 2026, its #5668 holding.
Farther Finance Advisors first reported a position in Immunocore in Q2 2024 and has held it in 6 quarters since.
Farther Finance Advisors's Immunocore position peaked at $8.02K in Q4 2025.
4 funds tracked by Wall St. Rank held Immunocore as of Q3 2026.

Based on Farther Finance Advisors's 13F filing for Q3 2026, filed 8 Oct 2026.